Modulatory function of invariant natural killer T cells in systemic lupus erythematosus.

Different subsets of natural killer T cells may vary in their roles in health and disease. Immunology (2014) 1.01

NKT Cell Subsets Can Exert Opposing Effects in Autoimmunity, Tumor Surveillance and Inflammation. Curr Immunol Rev (2012) 0.85

Chinese Herbal Medicine (Zi Shen Qing) for Mild-to-Moderate Systematic Lupus Erythematosus: A Pilot Prospective, Single-Blinded, Randomized Controlled Study. Evid Based Complement Alternat Med (2013) 0.77

Innate and Adaptive Immune Response in Fabry Disease. JIMD Rep (2015) 0.75

Effects of Invariant NKT Cells on Parasite Infections and Hygiene Hypothesis. J Immunol Res (2016) 0.75

The biology of NKT cells. Annu Rev Immunol (2007) 14.43

Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med (1994) 8.21

Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature (2005) 7.72

Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol (2007) 6.67

Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat Immunol (2003) 6.07

Systemic lupus erythematosus. Cell (1996) 4.21

Retracted Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat Immunol (2009) 3.84

Raising the NKT cell family. Nat Immunol (2010) 3.79

Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol (2008) 3.65

The unique role of natural killer T cells in the response to microorganisms. Nat Rev Microbiol (2007) 3.34

Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus (2000) 3.08

Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med (1998) 3.01

IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production. J Immunol (2007) 2.99

Glycolipid antigen induces long-term natural killer T cell anergy in mice. J Clin Invest (2005) 2.85

Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis. J Exp Med (1995) 2.63

Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clin Immunol (2008) 2.57

Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus. Arthritis Rheum (1999) 2.18

Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory. J Exp Med (2004) 2.10

The role of IL-23/IL-17 axis in lupus nephritis. J Immunol (2009) 2.06

Remnants of secondarily necrotic cells fuel inflammation in systemic lupus erythematosus. Arthritis Rheum (2009) 2.04

Low-dose peptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory T cells and contraction of inflammatory Th17 cells. J Immunol (2007) 1.88

Critical role of ROR-γt in a new thymic pathway leading to IL-17-producing invariant NKT cell differentiation. Proc Natl Acad Sci U S A (2008) 1.87

Invariant NKT cells limit activation of autoreactive CD1d-positive B cells. J Exp Med (2010) 1.83

Dysfunction of T cell receptor AV24AJ18+, BV11+ double-negative regulatory natural killer T cells in autoimmune diseases. Arthritis Rheum (2001) 1.78

CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells. J Immunol (2003) 1.76

Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity. Lupus (1995) 1.63

Predominance of Th1 immune response in diffuse proliferative lupus nephritis. Arthritis Rheum (2001) 1.61

Activation of natural killer T cells in NZB/W mice induces Th1-type immune responses exacerbating lupus. J Clin Invest (2003) 1.55

Human TCR-alpha beta+ CD4- CD8- T cells can derive from CD8+ T cells and display an inflammatory effector phenotype. J Immunol (2009) 1.52

Immunoregulatory role of CD1d in the hydrocarbon oil-induced model of lupus nephritis. J Immunol (2003) 1.44

Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding ceramides. J Immunol (2004) 1.37

NKT cells prevent chronic joint inflammation after infection with Borrelia burgdorferi. Proc Natl Acad Sci U S A (2008) 1.35

Laser microdissection-based analysis of cytokine balance in the kidneys of patients with lupus nephritis. Clin Exp Immunol (2009) 1.34

CD1d and invariant NKT cells at the human maternal-fetal interface. Proc Natl Acad Sci U S A (2002) 1.30

Repeated alpha-galactosylceramide administration results in expansion of NK T cells and alleviates inflammatory dermatitis in MRL-lpr/lpr mice. J Immunol (2003) 1.29

Clearance of apoptotic cells in human SLE. Curr Dir Autoimmun (2006) 1.29

Increase in IL-21 producing T-cells in patients with systemic lupus erythematosus. Arthritis Res Ther (2011) 1.26

Cutting edge: analysis of human V alpha 24+CD8+ NK T cells activated by alpha-galactosylceramide-pulsed monocyte-derived dendritic cells. J Immunol (2002) 1.21

The natural killer T cell ligand alpha-galactosylceramide prevents or promotes pristane-induced lupus in mice. Eur J Immunol (2005) 1.20

Production of a novel class of polyreactive pathogenic autoantibodies in BXD2 mice causes glomerulonephritis and arthritis. Arthritis Rheum (2006) 1.20

CD1d deficiency exacerbates inflammatory dermatitis in MRL-lpr/lpr mice. Eur J Immunol (2004) 1.18

Examining the role of CD1d and natural killer T cells in the development of nephritis in a genetically susceptible lupus model. Arthritis Rheum (2007) 1.18

Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity. J Clin Immunol (2009) 1.16

IL-17 induces autoantibody overproduction and peripheral blood mononuclear cell overexpression of IL-6 in lupus nephritis patients. Chin Med J (Engl) (2003) 1.15

Activation of invariant NKT cells by the helminth parasite schistosoma mansoni. J Immunol (2006) 1.13

Subsets of transgenic T cells that recognize CD1 induce or prevent murine lupus: role of cytokines. J Exp Med (1998) 1.11

C-reactive protein in rheumatology: biology and genetics. Nat Rev Rheumatol (2011) 1.10

Selective reduction and recovery of invariant Valpha24JalphaQ T cell receptor T cells in correlation with disease activity in patients with systemic lupus erythematosus. J Rheumatol (2001) 1.10

Natural killer T cells in families of patients with systemic lupus erythematosus: their possible role in regulation of IGG production. Arthritis Rheum (2007) 1.10

Apoptotic cells activate NKT cells through T cell Ig-like mucin-like-1 resulting in airway hyperreactivity. J Immunol (2010) 1.08

Expansion and hyperactivity of CD1d-restricted NKT cells during the progression of systemic lupus erythematosus in (New Zealand Black x New Zealand White)F1 mice. J Immunol (2005) 1.08

Natural killer T cells and innate immune B cells from lupus-prone NZB/W mice interact to generate IgM and IgG autoantibodies. Eur J Immunol (2008) 1.06

Reduced proportions of natural killer T cells are present in the relatives of lupus patients and are associated with autoimmunity. Arthritis Res Ther (2008) 1.03

Granzyme B cleavage of autoantigens in autoimmunity. Cell Death Differ (2010) 1.03

Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities. Tissue Antigens (2009) 1.01

Invariant NKT cells and tolerance. Int Rev Immunol (2007) 1.01

Numerical and functional deficiencies of natural killer T cells in systemic lupus erythematosus: their deficiency related to disease activity. Rheumatology (Oxford) (2011) 1.01

Decreased CD161+CD8+ T cells in the peripheral blood of patients suffering from rheumatic diseases. Rheumatology (Oxford) (2006) 0.97

Invariant NKT cells inhibit autoreactive B cells in a contact- and CD1d-dependent manner. J Immunol (2011) 0.97

NKT cells and autoimmune diseases: unraveling the complexity. Curr Top Microbiol Immunol (2007) 0.97

Measurement of intracellular interferon-gamma and interleukin-4 in whole blood T lymphocytes from patients with systemic lupus erythematosus. Immunol Lett (2000) 0.92

Cytokines expression in SLE nephritis. Eur Rev Med Pharmacol Sci (2011) 0.91

Beta-galactosylceramide alters invariant natural killer T cell function and is effective treatment for lupus. Clin Immunol (2009) 0.91

Ultraviolet-A1 phototherapy modulates Th1/Th2 and Tc1/Tc2 balance in patients with systemic lupus erythematosus. Rheumatology (Oxford) (2005) 0.90

Endogenous collagen peptide activation of CD1d-restricted NKT cells ameliorates tissue-specific inflammation in mice. J Clin Invest (2010) 0.88

Apoptosis and autoimmunity. Immunol Res (2006) 0.85

TCR AV24 gene expression in double negative T cells in systemic lupus erythematosus. Lupus (1998) 0.82

The role of iNKT cells in the immunopathology of systemic lupus erythematosus. Ann N Y Acad Sci (2009) 0.82

Role of invariant natural killer T (iNKT) cells in systemic lupus erythematosus. Curr Med Chem (2008) 0.81

Real-time tracheal ultrasonography for confirmation of endotracheal tube placement during cardiopulmonary resuscitation. Resuscitation (2013) 4.12

Tracheal rapid ultrasound exam (T.R.U.E.) for confirming endotracheal tube placement during emergency intubation. Resuscitation (2011) 3.34

SPAK-knockout mice manifest Gitelman syndrome and impaired vasoconstriction. J Am Soc Nephrol (2010) 2.73

Plectranthus amboinicus attenuates inflammatory bone erosion in mice with collagen-induced arthritis by downregulation of RANKL-induced NFATc1 expression. J Rheumatol (2011) 2.08

Multiplex PCR system for rapid detection of pathogens in patients with presumed sepsis - a systemic review and meta-analysis. PLoS One (2013) 1.94

Single nucleotide polymorphism at Fas promoter is associated with cervical carcinogenesis. Int J Cancer (2003) 1.71

Celecoxib and radioresistant glioblastoma-derived CD133+ cells: improvement in radiotherapeutic effects. Laboratory investigation. J Neurosurg (2010) 1.70

Dengue virus type 2 antagonizes IFN-alpha but not IFN-gamma antiviral effect via down-regulating Tyk2-STAT signaling in the human dendritic cell. J Immunol (2005) 1.63

Aggressive hepatic resection for patients with pyogenic liver abscess and APACHE II score > or =15. Am J Surg (2008) 1.63

Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. Proc Natl Acad Sci U S A (2010) 1.63

Ultrasonographic lung sliding sign in confirming proper endotracheal intubation during emergency intubation. Resuscitation (2011) 1.57

Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility. PLoS Genet (2011) 1.49

Identification of a systemic lupus erythematosus susceptibility locus at 11p13 between PDHX and CD44 in a multiethnic study. Am J Hum Genet (2010) 1.43

Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study. Am J Hum Genet (2012) 1.41

Supine to prolonged lateral position: a novel therapeutic maneuver for posterior canal benign paroxysmal positional vertigo. J Neurol (2012) 1.40

Recognition of molecularly imprinted polymers for a quaternary alkaloid of berberine. Talanta (2011) 1.39

SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway. Gynecol Oncol (2008) 1.28

Impaired phosphorylation of Na(+)-K(+)-2Cl(-) cotransporter by oxidative stress-responsive kinase-1 deficiency manifests hypotension and Bartter-like syndrome. Proc Natl Acad Sci U S A (2011) 1.25

Etiology of vocal cord paralysis. ORL J Otorhinolaryngol Relat Spec (2007) 1.22

Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis. Arthritis Rheum (2006) 1.21

Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells. J Biomed Sci (2011) 1.20

The fate of outer hair cells after acoustic or ototoxic insults. Hear Res (2006) 1.20

Current status of the immunomodulation and immunomediated therapeutic strategies for multiple sclerosis. Clin Dev Immunol (2011) 1.18

Varicella zoster virus infection of the pharynx and larynx with multiple cranial neuropathies. Laryngoscope (2011) 1.15

Attenuation of Th1 response through galectin-9 and T-cell Ig mucin 3 interaction inhibits autoimmune diabetes in NOD mice. Eur J Immunol (2009) 1.14

A secondary middle turbinate co-existing with an accessory middle turbinate: an unusual combination of two anatomic variations. Acta Otolaryngol (2006) 1.13

Association of a common complement receptor 2 haplotype with increased risk of systemic lupus erythematosus. Proc Natl Acad Sci U S A (2007) 1.13

Evaluation of protective efficacy and immune mechanisms of using a non-structural protein NS1 in DNA vaccine against dengue 2 virus in mice. Vaccine (2003) 1.10

A foreign body embedded in the mobile tongue masquerading as a neoplasm. Eur Arch Otorhinolaryngol (2002) 1.09

Chordoma stem cells. J Neurosurg (2013) 1.07

Chordoma. J Neurosurg Spine (2013) 1.07

Atypical meningioma. J Neurosurg (2013) 1.07

Fine mapping of Xq28: both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groups. Ann Rheum Dis (2012) 1.07

Invasive Brevundimonas vesicularis bacteremia: two case reports and review of the literature. J Microbiol Immunol Infect (2012) 1.07

Growth inhibition of ovarian tumor-initiating cells by niclosamide. Mol Cancer Ther (2012) 1.06

Cell transplantation. J Neurosurg (2013) 1.04

Isolation and characterization of tumor stem-like cells from human meningiomas. J Neurooncol (2010) 1.02

Transgenic expression of decoy receptor 3 protects islets from spontaneous and chemical-induced autoimmune destruction in nonobese diabetic mice. J Exp Med (2004) 1.02

Retinoic acid blocks pro-inflammatory cytokine-induced matrix metalloproteinase production by down-regulating JNK-AP-1 signaling in human chondrocytes. Biochem Pharmacol (2005) 1.02

Generation and analysis of the thiazide-sensitive Na+ -Cl- cotransporter (Ncc/Slc12a3) Ser707X knockin mouse as a model of Gitelman syndrome. Hum Mutat (2010) 1.01

Impact of underlying diseases on the clinical characteristics and outcome of primary pyomyositis. J Microbiol Immunol Infect (2008) 1.01

Inhibition of Nodal suppresses angiogenesis and growth of human gliomas. J Neurooncol (2010) 1.01

Longitudinal myelitis as an initial manifestation of systemic lupus erythematosus. Am J Med Sci (2004) 1.00

Triptolide exerts anti-tumor effect on oral cancer and KB cells in vitro and in vivo. Oral Oncol (2009) 1.00

Aberrant cytokines/chemokines production correlate with proteinuria in patients with overt diabetic nephropathy. Clin Chim Acta (2010) 0.99

Promoter methylation of SFRPs gene family in cervical cancer. Gynecol Oncol (2008) 0.99

Role of T cells in type 2 diabetic nephropathy. Exp Diabetes Res (2011) 0.99

Pigment epithelium-derived factor induces THP-1 macrophage apoptosis and necrosis by the induction of the peroxisome proliferator-activated receptor gamma. Mol Immunol (2007) 0.98

Chondroprotective effects and mechanisms of resveratrol in advanced glycation end products-stimulated chondrocytes. Arthritis Res Ther (2010) 0.98

Effects of various body temperatures after lipopolysaccharide-induced lung injury in rats. Chest (2005) 0.97

Recurrent deep intronic mutations in the SLC12A3 gene responsible for Gitelman's syndrome. Clin J Am Soc Nephrol (2010) 0.97

Adenoid cystic carcinoma of the external auditory canal. J Chin Med Assoc (2012) 0.96

Probing local ionic dynamics in functional oxides at the nanoscale. Nano Lett (2013) 0.96

Dehiscent high jugular bulb: a pitfall in middle ear surgery. Otol Neurotol (2006) 0.96

Experimental model of membranous nephropathy in mice: sequence of histological and biochemical events. Lab Anim (2008) 0.95

Erythropoietin enhances endogenous haem oxygenase-1 and represses immune responses to ameliorate experimental autoimmune encephalomyelitis. Clin Exp Immunol (2010) 0.94

Triptolide circumvents drug-resistant effect and enhances 5-fluorouracil antitumor effect on KB cells. Anticancer Drugs (2010) 0.94

Nucleic acid amplification using microfluidic systems. Lab Chip (2013) 0.94

Multipotent human mesenchymal stromal cells mediate expansion of myeloid-derived suppressor cells via hepatocyte growth factor/c-met and STAT3. Stem Cell Reports (2013) 0.94

Usefulness of erythrocyte-bound C4d as a biomarker to predict disease activity in patients with systemic lupus erythematosus. Rheumatology (Oxford) (2009) 0.93

A novel mechanism underlies the hepatotoxicity of pyrazinamide. Antimicrob Agents Chemother (2013) 0.92

A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: safety and immunity. Vaccine (2010) 0.92

Usefulness of anti-CCP antibodies in patients with hepatitis C virus infection with or without arthritis, rheumatoid factor, or cryoglobulinemia. Clin Rheumatol (2007) 0.92

EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas. J Neurooncol (2013) 0.92

An unrecognized cause of oedema in a patient with lupus nephritis: protein losing enteropathy. Nephrol Dial Transplant (2004) 0.91

Bacteroides fragilis bacteremia associated with portal vein and superior mesentery vein thrombosis secondary to antithrombin III and protein C deficiency: a case report. J Microbiol Immunol Infect (2002) 0.91

G(alpha)12-mediated pathway promotes invasiveness of nasopharyngeal carcinoma by modulating actin cytoskeleton reorganization. Cancer Res (2009) 0.91

Polyacetylenic compounds and butanol fraction from Bidens pilosa can modulate the differentiation of helper T cells and prevent autoimmune diabetes in non-obese diabetic mice. Planta Med (2004) 0.91

Immunologic regulation in pregnancy: from mechanism to therapeutic strategy for immunomodulation. Clin Dev Immunol (2011) 0.91

A clinical study to assess the immunogenicity and safety of a monovalent 2009 influenza A (H1N1) vaccine in an area with low-level epidemics of pandemic influenza. Vaccine (2010) 0.91

Effects of minocycline on Fas-mediated fulminant hepatitis in mice. Br J Pharmacol (2005) 0.91

An on-chip Cell-SELEX process for automatic selection of high-affinity aptamers specific to different histologically classified ovarian cancer cells. Lab Chip (2014) 0.91

Osteopontin expression is a valuable marker for prediction of short-term recurrence in WHO grade I benign meningiomas. J Neurooncol (2010) 0.90

Differential effects of triptolide and tetrandrine on activation of COX-2, NF-kappaB, and AP-1 and virus production in dengue virus-infected human lung cells. Eur J Pharmacol (2008) 0.90

Protective role of programmed death 1 ligand 1 (PD-L1)in nonobese diabetic mice: the paradox in transgenic models. Diabetes (2008) 0.90

Rapid detection of live methicillin-resistant Staphylococcus aureus by using an integrated microfluidic system capable of ethidium monoazide pre-treatment and molecular diagnosis. Biomicrofluidics (2012) 0.89

Epidermal inclusion cyst of the soft palate and uvula in an infant. Eur J Pediatr (2013) 0.89

Association of PPP2CA polymorphisms with systemic lupus erythematosus susceptibility in multiple ethnic groups. Arthritis Rheum (2011) 0.89

Preferential binding to Elk-1 by SLE-associated IL10 risk allele upregulates IL10 expression. PLoS Genet (2013) 0.89

HO-1 induction ameliorates experimental murine membranous nephropathy: anti-oxidative, anti-apoptotic and immunomodulatory effects. Nephrol Dial Transplant (2008) 0.88

Triggering of DC migration by dengue virus stimulation of COX-2-dependent signaling cascades in vitro highlights the significance of these cascades beyond inflammation. Eur J Immunol (2009) 0.88

Ocular responses and visual performance after high-acceleration force exposure. Invest Ophthalmol Vis Sci (2009) 0.88

Cytokines in diabetic nephropathy. Adv Clin Chem (2012) 0.88

Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis. J Microbiol Immunol Infect (2008) 0.87

A novel family of cyst proteins with epidermal growth factor repeats in Giardia lamblia. PLoS Negl Trop Dis (2010) 0.87

Triptolide Transcriptionally Represses HER2 in Ovarian Cancer Cells by Targeting NF-κB. Evid Based Complement Alternat Med (2012) 0.86

Mesangial cells of lupus-prone mice are sensitive to chemokine production. Arthritis Res Ther (2007) 0.86

Dysregulated brain creatine kinase is associated with hearing impairment in mouse models of Huntington disease. J Clin Invest (2011) 0.86

Surface expression of HLA-G is involved in mediating immunomodulatory effects of placenta-derived multipotent cells (PDMCs) towards natural killer lymphocytes. Cell Transplant (2011) 0.86

Transgenic expression of single-chain anti-CTLA-4 Fv on beta cells protects nonobese diabetic mice from autoimmune diabetes. J Immunol (2009) 0.86

Carvedilol, a new antioxidative beta-blocker, blocks in vitro human peripheral blood T cell activation by downregulating NF-kappaB activity. Cardiovasc Res (2003) 0.85

Different modulation of Ptpn22 in effector and regulatory T cells leads to attenuation of autoimmune diabetes in transgenic nonobese diabetic mice. J Immunol (2013) 0.85

Cryptococcal disease in patients with or without human immunodeficiency virus: clinical presentation and monitoring of serum cryptococcal antigen titers. J Microbiol Immunol Infect (2009) 0.85

Blood-brain barrier. J Neurosurg (2013) 0.85

Decoy receptor 3 ameliorates an autoimmune crescentic glomerulonephritis model in mice. J Am Soc Nephrol (2007) 0.85

The evaluation of Game-Based e-learning for medical education: a preliminary survey. AMIA Annu Symp Proc (2005) 0.85